Journal of Immunology Research · 2022 · 15 citations · 12 references
MedicineCancer BiologyOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer Molecular PathologyCancer TranscriptomicsHepatocellular CarcinomaImmuno-oncology BiomarkersMalignant NeoplasmsTumor ImmunopathologyHepatocellular Carcinoma PathogenesisImmune InfiltratesImmune Infiltration BiomarkersImmune Infiltration Prognostic SignaturesMolecular Prognostic MarkersPrognostic Marker AssessmentPrognostic Marker EvaluationPrognostic Prediction
Hepatocellular carcinoma (HCC) remains an incurable disease with a very poor clinical outcome. The purpose of this article was to investigate whether the expression or methylation of tetrapeptide repeat domain 36 (TTC36) could be used as a prognostic marker in hepatocellular carcinoma. TCGA database was used to obtain information on HCC gene expression and the associated clinical features of HCC patients. Differentially expressed genes (DEGs) were screened between 374 HCC specimens and 50 nontumor specimens. The expression and prognostic value of TTC36 were analyzed. The correlations between TTC36 and cancer immune infiltrates were investigated via TIMER. In this study, HCC specimens and nontumor specimens were compared and 35 DEGs were found between them. Among the 35 DEGs, the expression of TTC36 was significantly reduced in HCC samples compared with nontumor samples. Survival tests revealed that patients with low TTC36 expression had a shorter overall survival than patients with high TTC36 expression. TTC36 was found to be an independent predictive factor for HCC in both univariate and multivariate regression analyses. TTC36 was negatively regulated by TTC36 methylation, leading to its low expression in HCC tissues. Immune analysis revealed that TTC36 expression has significant correlations with B cell, T cell CD4+, neutrophil, macrophage, and myeloid dendritic cell. Finally, TTC36 expression was dramatically reduced in HCC cells, and overexpression greatly suppressed HCC cell proliferation and invasion, according to our experimental results. Overall, our data suggested that TTC36 could be applied as a prognostic marker for predicting outcome and immune infiltration in HCC.
12
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu, Li-Gen Wang, Yanyan Han et al. · OMICS A Journal of Integrative Biology · 2012 · 38.3K citations
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2020 · 21.4K citations · Full text
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li, Jing‐Yu Fan, Binbin Wang et al. · Cancer Research · 2017 · 6.6K citations · Full text
Life Sciences, Immunology, Oncology +17
DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma
Augusto Villanueva, Anna Portela, Sergi Sayols et al. · Hepatology · 2015 · 446 citations · Full text